1.
Yeh MM.
Pathology of combined hepatocellular-cholangiocarcinoma.
J Gastroenterol Hepatol 2010;25:1485–1492.
2.
Allen RA,
Lisa JR.
Combined liver cell and bile duct carcinoma.
Am J Pathol 1949;25:647–655.
3.
Kim H,
Park C,
Han H-K et al.
“Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype,”Journal of Hepatology,vol.
40,
no.
2,
pp.
298–304,
2004.
4.
Zhang F,
Chen X-P,
Zhang W et al.
“Combined hepa- tocellular cholangiocarcinoma originating from hepatic pro- genitor cells: immunohistochemical and double-fluorescence immunostaining evidence,”Histopathology,vol.
52,
no.
2,
pp.
224–232,
2008.
5.
Kassahun WT,
Hauss J.
Management of combined hepatocellular and cholangiocarcinoma.
Int J Clin Pract 2008;62:1271–1278.
6.
Kim JH,
Yoon HK,
Ko GY,
et al.
Nonresectable combined hepato-
cellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial che- moembolization.
Radiology 2010;255:270–277.
7.
Aoki K,
Takayasu K,
Kawano T,
et al.
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and com- puted tomographic findings.
Hepatology 1993;18:1090–1095.
8.
Yano Y,
Yamamoto J,
Kosuge T,
et al.
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Jpn J Clin Oncol 2003;33:283–287.
9.
Wang J,
Wang F,
Kessinger A. Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver. Journal of Oncology, Vol.
2010,
7pages